Scholarlink

<p>Lupus nephritis (LN), a severe organ manifestation of systemic lupus erythematosus (SLE), is primarily driven by an imbalance between pathogenic Th17 cells and regulatory T (Treg) cells. We found that NK cell-derived extracellular vesicles (NK-EVs) from LN patients, but not healthy controls, exhibited a distinct miRNA cargo that potently drives Th17 polarization. Small RNA sequencing identified miR-1290 as the most significantly upregulated miRNA in NK-EVs derived from LN patients. This finding was validated in an independent clinical cohort, where miR-1290 levels correlated with key disease activity indices. Functional analysis revealed that miR-1290 promoted Th17 differentiation and suppressed Treg generation by downregulating NR4A2. In the MRL<i>/lpr</i> lupus mice, systemic delivery of NK-EVs engineered to carry a miR-1290 antagomir restored the Th17/Treg balance, alleviated renal inflammation and fibrosis. Collectively, we found miR-1290 in NK-EVs disrupted T cell homeostasis by targeting NR4A2, driving Th17/Treg imbalance. Delivering miR-1290 antagomirs via engineered NK-EVs restored this balance and alleviated renal damage in LN mice.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MiR-1290 in natural killer cell derived extracellular vesicles: a pathogenic mediator of lupus nephritis and therapeutic target for th17 regulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月2日

查看全文
  • Chen Cheng,
  • Huanhou Su,
  • Xin Li,
  • Ru Li,
  • Qian Yang,
  • Tianwang Guan,
  • Minmin Li,
  • Caiwen Ou

摘要

Lupus nephritis (LN), a severe organ manifestation of systemic lupus erythematosus (SLE), is primarily driven by an imbalance between pathogenic Th17 cells and regulatory T (Treg) cells. We found that NK cell-derived extracellular vesicles (NK-EVs) from LN patients, but not healthy controls, exhibited a distinct miRNA cargo that potently drives Th17 polarization. Small RNA sequencing identified miR-1290 as the most significantly upregulated miRNA in NK-EVs derived from LN patients. This finding was validated in an independent clinical cohort, where miR-1290 levels correlated with key disease activity indices. Functional analysis revealed that miR-1290 promoted Th17 differentiation and suppressed Treg generation by downregulating NR4A2. In the MRL/lpr lupus mice, systemic delivery of NK-EVs engineered to carry a miR-1290 antagomir restored the Th17/Treg balance, alleviated renal inflammation and fibrosis. Collectively, we found miR-1290 in NK-EVs disrupted T cell homeostasis by targeting NR4A2, driving Th17/Treg imbalance. Delivering miR-1290 antagomirs via engineered NK-EVs restored this balance and alleviated renal damage in LN mice.

Graphical Abstract